GSK is committed to helping patients regain control of their breathing by understanding their experiences and answering the key scientific questions that affect their lives. GSK’s scientists constantly seek innovated approaches to ensure Healthcare Professionals can make the most informed decisions about patients’ health and feel empowered in their respiratory treatment choices. Our global investments in the latest scientific research enable GSK’s dedicated respiratory teams to develop the most innovate new treatments that help people to breathe better.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas – Oncology; BioPharmaceuticals; Vaccine and Immune Therapies; and Rare Disease. We collaborate with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. At AstraZeneca Australia-New Zealand, we have been working to deliver the best value to patients for more than 60 years, and we push the boundaries of science to deliver life-changing medicines. AstraZeneca is harnessing the power of science and innovation and our global reach to build a healthy future for people, society, and the planet.
The Organising Committee welcomes all inquiries from industry partners for sponsorship and exhibition investment at the New Zealand Branch Meeting.
Please contact our Conference Managers to review investment opportunities, or for further information.